Clinical Trials · NCT06326047
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 299
- Start date
- Mar 2024
- Locations
- 94 sites, 7 countries
- Primary endpoint
- Change in Glycated haemoglobin (HbA1c)